Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Infectious mononucleosis.

Patrick G P Charles1

  • 1Victorian Infectious Disease Reference Laboratory, North Melbourne, Victoria. patrick.charles@mh.org.au

Australian Family Physician
|November 5, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effective real-world outcomes of remdesivir provided under compassionate access for moderate/severe COVID-19 in Australia.

Internal medicine journal·2025
Same author

COVID-19 infection among patients with cancer in Australia from 2020 to 2022: a national multicentre cohort study.

The Lancet regional health. Western Pacific·2023
Same author

A vaccination update for rheumatologists-SARS-CoV-2, influenza and herpes zoster.

International journal of rheumatic diseases·2021
Same author

Large paraspinal abscess as a complication of infliximab therapy in Crohn's disease.

BMJ case reports·2019
Same author

Old but not forgotten: Antibiotic allergies in General Medicine (the AGM Study).

The Medical journal of Australia·2016
Same author

Endoscopic investigation in non-iron deficiency anemia: a cost to the health system without patient benefit.

Endoscopy international open·2016
Same journal

Occupational violence and staff safety in general practice.

Australian family physician·2018
Same journal

You should get that mole checked out: Ethical and legal considerations of the unsolicited clinical opinion.

Australian family physician·2018
Same journal

Understanding the decision to commence a dose administration aid.

Australian family physician·2018
Same journal

Psychological distress and risky sexual behaviours among women aged 16-25 years in Victoria, Australia.

Australian family physician·2018
Same journal

A mixed-methods feasibility study of routinely weighing patients in general practice to aid weight management.

Australian family physician·2018
Same journal

The Australian Mid-West Coastal Marine Wound Infections Study.

Australian family physician·2018
See all related articles

Most infectious mononucleosis cases resolve with supportive care. Severe cases may need hospitalization, with corticosteroids used cautiously for complications, while antiviral therapy offers no proven benefit.

Area of Science:

  • Infectious Diseases
  • Virology
  • Immunology

Background:

  • Infectious mononucleosis is a common illness caused by Epstein-Barr virus (EBV), primarily affecting adolescents and young adults.
  • While typically mild to moderate, EBV can lead to severe cases and rare complications.

Observation:

  • This review presents a case of severe infectious mononucleosis to illustrate the disease spectrum.
  • Diagnostic approaches, potential complications, and management strategies are discussed.

Findings:

  • The majority of infectious mononucleosis cases are self-limiting, requiring only supportive care.
  • Severe manifestations may necessitate hospital admission, potentially including intensive care.
  • Corticosteroid therapy is reserved for severe complications like airway obstruction, balancing risks and benefits.

Related Experiment Videos

  • Antiviral medications have demonstrated no proven efficacy in treating infectious mononucleosis.

    • Implications:

    • Understanding the spectrum of infectious mononucleosis is crucial for appropriate patient management.
    • Judicious use of corticosteroids is advised for severe complications, avoiding unnecessary risks.
    • Current evidence does not support antiviral therapy for infectious mononucleosis, emphasizing supportive care.